Oncotarget is a medical journal that is peer-reviewed and has open access to all. They publish articles on a weekly basis. It began being published in 2010 by Impact Journals. Oncotarget covers all the different aspects of oncology including the pathological basis for all different types of cancer, the potential targets for different types of therapy and also the different treatment protocols that are made to improve the management of all patients suffering from cancer. Andrei Gudkov and Mikhail Blagosklonny are both the editors-in-chief of Oncotarget.
This online medical journal has recently had a rise in popularity. This is because of the insightful and the constructive information that it holds. It also is because it is peer-reviewed by multiple people and it comes out on time each week. Although Oncotarget focuses on oncology, they also accept papers on topics that aren’t all related to oncology. These topics include Endocrinology, Neuroscience, Cell Biology, Cardiology, Metabolism, Pharmacology and many more. In addition to all of this, the journal also has a focus on the type of impact that management programs have as well as the new therapeutic agents and the different protocols on patient perspective. These protocols include their quality of life and their satisfaction as well as adherence. Download output styles at Endnote.com.
The mission of Oncotarget is to make many different scientific results quickly and widely available to all who are interested. This is done in hopes to maximize the impact that research has by all of the different insightful reviews. There is also a goal of having the exceptional discoveries that are found be able to be shared quickly to all. They strive to be able to eliminate the boarder that occurs between different specialties and to also be able to link all of the different fields of biomedical science. This journal gives all researchers who are interested the ability to contribute to the progression of science. The ultimate goal is to be able to live life without disease. It also explores all of the evidence that is behind new therapies as well as existing therapies. It explores the improving outcomes and also seeks to be able to define the usage in terms of acceptance by not only the health care professionals but also the patients. Oncotarget, which is published by Impact Journals